Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   Specific RITA modification produces hyperselective cytotoxicity while maintaining in vivo antitumor efficacy
  2. Peyser,Brian; Hermone,Ann; Salamoun, Joseph M; Burnett, James C; Hollingshead,Melinda; McGrath,Connor; Gussio,Rick; Wipf, Peter
  3. Molecular cancer therapeutics. 2019, OCT; 18(10): 1765-1774.
  1. 2.   Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma
  2. Moslehi, R.; Chatterjee, N.; Church, T. R.; Chen, J.; Yeager, M.; Weissfeld, J.; Hein, D. W.; Hayes, R. B.
  3. Pharmacogenomics. 2006, Sep; 7(6): 819-829.
  1. 3.   Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells
  2. Ben-Kasus, T.; Ben-Zvi, Z.; Marquez, V. E.; Kelley, J. A.; Agbaria, R.
  3. Biochemical Pharmacology. 2005, JUL 1; 70(1): 121-133.
  1. 4.   The experimental antitumor agents Phortress and Doxorubicin are equiactive against human-derived breast carcinoma xenograft models
  2. Fichtner, I.; Monks, A.; Hose, C.; Stevens, M. F. G.; Bradshaw, T. D.
  3. Breast Cancer Research and Treatment. 2004, SEP; 87(1): 97-107.
  1. 5.   Aryl hydrocarbon receptor activation of an antitumor aminoflavone: Basis of selective toxicity for MCF-7 breast tumor cells
  2. Loaiza-Perez, A. I.; Kenney, S.; Boswell, J.; Hollingshead, M.; Alley, M. C.; Hose, C.; Ciolino, H. P.; Yeh, G. C.; Trepel, J. B.; Vistica, D. T.; Sausville, E. A.
  3. Molecular Cancer Therapeutics. 2004 3(6): 715-725.
  1. 6.   Potent inhibition of HhaI DNA methylase by the aglycon of 2-(1H)-pyrimidinone riboside (Zebularine) at the G(C)under-barGC recognition domain
  2. Marquez, V. E.; Eritja, R.; Kelley, J. A.; Vanbemmel, D.; Christman, J.
  3. THERAPEUTIC OLIGONUCLEOTIDES. 2003; 1002 : 154-164.
  1. 7.   Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4- amino-3-methylphenyl]-5-fluoro-benzothiazole: A potential surrogate marker for patient sensitivity
  2. Hose, C. D.; Hollingshead, M.; Sausville, E. A.; Monks, A.
  3. Molecular Cancer Therapeutics. 2003 2(12): 1265-1272.
  1. 8.   DNA adducts of 2-amino-3-methylimidazo
  2. Josyula, S.; Lu, L. J. W.; Salazar, J. J.; Nerurkar, P. V.; Jones, A. B.; Grady, J. J.; Snyderwine, E. G.; Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2000 166(3): 151-160.
  1. 9.   Factors determining mutagenic potential for individual cis and trans opened benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts
  2. Ponten, I.; Sayer, J. M.; Pilcher, A. S.; Yagi, H.; Kumar, S.; Jerina, D. M.; Dipple, A.
  3. Biochemistry. 2000 39(14): 4136-4144.
  1. 10.   DNA adducts from syn 7-methylbenz
  2. Szeliga, J.; Harvey, R. G.; Cortez, C.; Dipple, A.
  3. Polycyclic Aromatic Compounds. 1999 13(1): 41-53.
  1. 11.   CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice
  2. Kimura, S.; Kawabe, M.; Ward, J. M.; Morishima, H.; Kadlubar, F. F.; Hammons, G. J.; Fernandez-Salguero, P.; Gonzalez, F. J.
  3. Carcinogenesis. 1999 20(9): 1825-1830.
  1. 12.   Dna Adduct Formation By Polycyclic Aromatic Hydrocarbon Dihydrodiol Epoxides
  2. Szeliga, J.; Dipple, A.
  3. Chemical Research in Toxicology. 1998 11(1): 1-11.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel